Association of methylene tetrahydrofolate reductase c677t genotype with type 2 diabetes mellitus patients with and without renal complications

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 4, 2011, Pages 257-261

  Movva, Sireesha ^a,b   Alluri, Ravindra V ^c   Venkatasubramanian, Sambasivan ^a   Vedicherla, Bhavani ^a   Vattam, Kiran K ^c   Ahuja, Yog R ^b   Hasan, Qurratulain ^a,b,c  

^a Mahavir Charitable Hospital   (India)

^b Vasavi Hospital   (India)

^c KAMINENI HOSPITALS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GLUCOSE;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INDIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK; SCREENING;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 79953071421     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0118     Document Type: Article

References (30)

1. Adiga MNS, Chandy S, Ramachandra N, et al. (2010) Methylenetetrahydrofolate reductase gene polymorphisms and risk of lymphoblastic leukemia in children. Indian J Cancer 47:40-45.
2. Alluri RV, Mohan V, Komandur S, et al. (2005) MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur J Neurol 12:40-44.
3. American Diabetes Association (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1187-1201.
4. Boger CA, Stubanus M, Haak T, et al. (2007) Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nephrol Dial Transplant 22:154-162. (Pubitemid 46050340)
5. Bruntgens A, Schmidt S, Strojek K, et al. (1999) Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes? Nephrol Dial Transplant 14:56-57. (Pubitemid 29041867)
6. Eroglu Z, Erdogan M, Tetik A, et al. (2007) The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. Diabetes Metab Res Rev 8:621-624. (Pubitemid 350200401)
7. Frosst P, Blom HJ, Kluijtmans LAJ, et al. (1995) A candidate genetic risk factor for common mutation in methylenetetrahydrofalate reductase. Nat Genet 10:111-113.
8. Fuks F, Hurd PJ, Wolf D, et al. (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278:4035-4040. (Pubitemid 36801137)
9. Guldener CV, Stehouwer CDA (2002) Diabetes mellitus and hyperhomocysteinemia. Semin Vasc Med 2:351-359.
10. Keane WF, Eknoyan G (1999) Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 33:1004-1010. (Pubitemid 29214705)
11. Keane WF, Kurokawa K, Lyle PA, et al. (2002) Treatment of type 2 diabetic patients with kidney disease with AT1-receptor antagonists: lessons from recent trials. Clin Exp Nephrol 6:175-181. (Pubitemid 36119631)
12. Ksiażek P, Bednarek-Skublewskabcf A, Buraezyńska M (2004) The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med Sci Monit 10:47-51.
13. Maeda M, Yamamoto I, Fukuda M, et al. (2008) MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients. J Diabetes Complications 2:119-125. (Pubitemid 351226616)
14. Minna S, Jukka M, Markku L, et al. (2004) Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Inter Med 140:94-100.
15. Mtiraoui N, Ezzidi I, Chaieb M, et al. (2007) MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract 75:99-106. (Pubitemid 44856026)
16. Naushad SM, Jain Jamal MN, Prasad CK, et al. (2008) Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians. Clin Chem Lab Med 46:73-79.
17. Nygard O, Refsum H, Ueland PM, et al. (1998) Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 67:263-270. (Pubitemid 28076718)
18. Obineche EN, Adem A (2005) Update in diabetic nephropathy. Int J Diabetes Metab 13:1-9.
19. Odawara M, Yamashita K, Yamada N (1999) MTHFR gene variant is not associated with diabetic nephropathy in Japanese. Nucleic Acids Symp 42:85-86.
20. Panigrahi I, Chatterjee T, Biswas A, et al. (2006) Role of MTHFR C677T polymorphism in ischemic stroke. Neurol India 54:48-50.
21. Pastan S, Bailey J (1998) Dialysis therapy. N Engl J Med 338:428-437.
22. Pradhan M, Behari S, Kalra SK, et al. (2007) Association of methylenetetrahydrofolate reductase genetic polymorphisms with atlantoaxial dislocation. J Neurosurg Spine 7:623-630. (Pubitemid 350291546)
23. Saraswathy KN, Mukhopadhyay R, Sinha E, et al. (2008) MTHFR C677T polymorphisms among the Ahirs and Jats of Haryana (India). Am J Hum Biol 20:116-117.
24. Stam F, Guldener CV, Wee PMT, et al. (2005) Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease. Kidney Int 67:259-264. (Pubitemid 40019247)
25. Sun J, Xu Y, Xue J, et al. (2005) Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients. Mol Cell Endocrinol 14:95-101. (Pubitemid 40018087)
26. Sun J, Xu Y, Zhu Y, et al. (2003) The relationship between MTHFR gene polymorphism, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus. Chin Med J 116:145-147. (Pubitemid 36432742)
27. Sun J, Xu Y, Zhu Y, et al. (2004) Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 64:85-90.
28. Unnikrishnan RI, Rema M, Pradeepa R, et al. (2007) Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 30:2019-2024. (Pubitemid 47219412)
29. Wild S, Roglic G, Green A, et al. (2004) Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 27:5-8.
30. Zintzaras E, Chatzoulis DZ, Karabatsas CH, et al. (2005) The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet 50:267-275. (Pubitemid 41159982)